Clinical trial
The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV…
NCT00275665 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275665 |
|---|---|
| Title | The Study is Being Done to See if Taking the Drug Valganciclovir Can Prevent CMV Infection. |
| Official title | A Phase III Multicenter Study of Valganciclovir for the Prevention of Late Cytomegalovirus Infection After Allogenic Hematopoietic Stem Cell Transplantation. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Roche Pharma AG Industry Fred Hutchinson Cancer Center City of Hope National Medical Center University of Florida University of Michigan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bone Marrow Stem Cell Transplant |
| Intervention type | Drug |
| Interventions | Valganciclovir |
| Enrollment | 20 |
| Start date | Nov 1, 2001 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Dec 19, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: